▲   Shouzheng innovation - sub Forum on secondary development and large variety cultivation of traditional Chinese Medicine

On the morning of October 23, the 15th Zhang Zhongjing Medical Culture Festival and the 9th Zhongjing forum in Nanyang, China were grandly opened. The theme of this medical cultural festival is "inheriting the essence, guarding innovation, promoting the high quality development of Chinese medicine and industry", exploring the development of Chinese medicine and promoting the inheritance and innovation of traditional Chinese medicine culture. On the 24th, the "rightness and innovation - secondary development of traditional Chinese medicine and large variety cultivation forum" of Fusen pharmaceutical branch of this medical culture festival was held by the beautiful Danjiang lake. Leaders, experts, scholars and medical colleagues from all sides gathered together to give lectures, discuss Taoism, study scriptures, discuss the development plan of traditional Chinese medicine, and join hands to revitalize the health industry of traditional Chinese medicine.

I. speech by leaders

▲ speech by Zhang Changhe, deputy director of Nanyang traditional Chinese Medicine Development Bureau

At the meeting, Zhang Changhe, deputy director of the Nanyang Municipal Development Bureau of traditional Chinese medicine, pointed out that in May 12th this year, general secretary Xi Jinping visited Nanyang and made important instructions for the work of Chinese medicine, pointing out the way forward for the development of Chinese medicine. Nanyang is the hometown of Zhang Zhongjing, the medical saint. At present, Nanyang is working towards the grand goal of "global holy land of traditional Chinese medicine, national highland of traditional Chinese medicine and national famous capital of traditional Chinese medicine". As one of the leading enterprises of traditional Chinese medicine in Nanyang, Fusen pharmaceutical invited experts to deeply exchange the development opportunities of traditional Chinese medicine under the new situation and share the research results of secondary development and large variety cultivation of traditional Chinese medicine, which is not only of positive significance to the development of traditional Chinese medicine in Nanyang, but also bound to drive a large number of large varieties of traditional Chinese medicine to take off again and promote the rapid development of the traditional Chinese medicine industry.

▲   Mr. Cao Zhiming, President of Fusen pharmaceutical

Mr. Cao Zhiming, President of Fusen pharmaceutical, briefly introduced the enterprise profile and social contribution of Fusen pharmaceutical. President Cao has high hopes for the holding of this forum, and hopes that through this forum, everyone can further deepen their understanding and understanding of the development of traditional Chinese medicine, guide and promote the secondary development of traditional Chinese medicine with more scientific methods, and strengthen the positive and innovative development of traditional Chinese medicine industry, Make positive contributions to the leapfrog development of traditional Chinese medicine in the new historical period.

II. Expert report

▲   Deputy Secretary General Shen Nuo of China traditional Chinese Medicine Association made a report

Shen Nuo, Deputy Secretary General of China traditional Chinese Medicine Association, brought the report of "opportunities for traditional Chinese medicine industry under the new deal of traditional Chinese medicine". She elaborated the national strategic layout and policy support for traditional Chinese medicine industry under the new situation from four aspects: the new deal of traditional Chinese medicine, the development status and policy trend of traditional Chinese medicine industry, the strategic choice and strategic opportunities of traditional Chinese medicine industry, At the same time, it points out the development direction of traditional Chinese medicine industry in the future, and effectively improves everyone's confidence in the development of traditional Chinese medicine industry.

▲   Professor Wang Yi, Institute of pharmacoinformatics, Zhejiang University, made a report

Professor Wang Yi from the Institute of Pharmaceutical Informatics of Zhejiang University brought a special report on "Research on the secondary development and industrialization trend of Chinese patent medicine". Based on the background of the times and strategic needs, he expounded the core of the requirements for the inheritance, innovation and development of traditional Chinese medicine. Taking Tongmai oral liquid, Shuanghuanglian injection liquid and ganweikang tablets as examples, he creatively put forward the theory and strategy of the secondary development of large varieties of Chinese patent medicine, At the same time, based on the development of large health industry, imagine building a new traditional Chinese medicine industry system with industry as the core for upstream and downstream model innovation, and advocate the development of traditional Chinese medicine industry from extensive enterprises to quality-benefit enterprises.

Miao mingsan, vice president of Henan University of traditional Chinese medicine, made a special report on "secondary development and large variety cultivation of traditional Chinese medicine based on new use" at the meeting.

Dr. Gao Jin of the National Engineering and Technology Research Center for the modernization of traditional Chinese medicine brought a special report on "research and practice of secondary development and large variety cultivation of traditional Chinese medicine -- Taking Shenqi Fuzheng Injection and antiviral granules as examples".

Professor Fan Guanwei of Tianjin University of traditional Chinese medicine made a special report on "Research on pharmacodynamic material basis and action mechanism of Yuanhu Zhitong oral liquid".

Professor Xu Haiyu, Institute of traditional Chinese medicine, Chinese Academy of traditional Chinese medicine, made a special report on "integrated Pharmacology - Exploration and Research on Yuanhu Zhitong recipe".

Su Xiangfei, director of Standardization Office of Chinese society of traditional Chinese medicine, introduced at the meeting that "group standardization helps the high-quality development of traditional Chinese medicine industry".

III. unveiling ceremony

▲ Cao Zhiming, President of Fusen pharmaceutical, and Dr. Gao Jin of the national modern engineering technology center took a group photo for the unveiling

▲ group photo of the unveiling of the Branch Center for large varieties of traditional Chinese medicine and the Branch Center for research on the combination of medicine and nutrition

In order to further promote the secondary development and large variety cultivation of traditional Chinese medicine, the unveiling ceremony of the sub center of the National Engineering and Technology Research Center for the modernization of traditional Chinese medicine was held at the conference. Mr. Cao Zhiming, President of Fusen Pharmaceutical Co., Ltd. and Dr. Gao Jin of the National Engineering and Technology Research Center for the modernization of traditional Chinese medicine jointly unveiled the "National Engineering and Technology Research Center for the modernization of traditional Chinese medicine" and the "research sub center for the cultivation of large varieties of traditional Chinese Medicine" and the "research sub center for the combination of medicine and maintenance". The successful listing of the two sub centers marks a new step in the development of the modernization of traditional Chinese medicine of Fusen Pharmaceutical Co., Ltd.

▲ group photo of medical institutions and strategic partners of dealers

This forum is successfully concluded. In the future, forsen pharmaceutical company will unswervingly implement the development concept of "traditional Chinese medicine with the essence of inheritance and innovation", and make positive contributions to the development of China's traditional Chinese medicine.